ChemoMetec Valuation
| CHY Stock | EUR 64.25 0.50 0.78% |
At this time, the firm appears to be overvalued. ChemoMetec AS shows a prevailing Real Value of €51.64 per share. The current price of the firm is €64.25. Our model approximates the value of ChemoMetec AS from analyzing the firm fundamentals such as profit margin of 0.39 %, and Return On Equity of 0.49 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ChemoMetec's price fluctuation is not too volatile at this time. Calculation of the real value of ChemoMetec AS is based on 3 months time horizon. Increasing ChemoMetec's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ChemoMetec stock is determined by what a typical buyer is willing to pay for full or partial control of ChemoMetec AS. Since ChemoMetec is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ChemoMetec Stock. However, ChemoMetec's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 64.25 | Real 51.64 | Hype 63.75 | Naive 66.71 |
The real value of ChemoMetec Stock, also known as its intrinsic value, is the underlying worth of ChemoMetec AS Company, which is reflected in its stock price. It is based on ChemoMetec's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ChemoMetec's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ChemoMetec AS helps investors to forecast how ChemoMetec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ChemoMetec more accurately as focusing exclusively on ChemoMetec's fundamentals will not take into account other important factors: ChemoMetec Total Value Analysis
ChemoMetec AS is currently estimated to have takeover price of 1.93 B with market capitalization of 1.07 B, debt of 2.36 M, and cash on hands of 150.11 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ChemoMetec fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.93 B | 1.07 B | 2.36 M | 150.11 M |
ChemoMetec Investor Information
About 51.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 221.15. ChemoMetec AS last dividend was issued on the 9th of October 2020. Based on the measurements of operating efficiency obtained from ChemoMetec's historical financial statements, ChemoMetec AS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.ChemoMetec Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ChemoMetec has an asset utilization ratio of 85.46 percent. This implies that the Company is making €0.85 for each dollar of assets. An increasing asset utilization means that ChemoMetec AS is more efficient with each dollar of assets it utilizes for everyday operations.ChemoMetec Ownership Allocation
ChemoMetec holds a total of 17.4 Million outstanding shares. Over half of ChemoMetec's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in ChemoMetec. Please watch out for any change in the institutional holdings of ChemoMetec AS as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.ChemoMetec Profitability Analysis
The company reported the revenue of 428.39 M. Net Income was 159.47 M with profit before overhead, payroll, taxes, and interest of 384.25 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ChemoMetec's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ChemoMetec and how it compares across the competition.
About ChemoMetec Valuation
The stock valuation mechanism determines ChemoMetec's current worth on a weekly basis. Our valuation model uses a comparative analysis of ChemoMetec. We calculate exposure to ChemoMetec's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ChemoMetec's related companies.ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis in Denmark, the United States, Canada, rest of Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. CHEMOMETEC operates under Scientific Technical Instruments classification in Germany and is traded on Frankfurt Stock Exchange. It employs 147 people.
8 Steps to conduct ChemoMetec's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ChemoMetec's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ChemoMetec's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ChemoMetec's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ChemoMetec's revenue streams: Identify ChemoMetec's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ChemoMetec's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ChemoMetec's growth potential: Evaluate ChemoMetec's management, business model, and growth potential.
- Determine ChemoMetec's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ChemoMetec's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ChemoMetec Stock analysis
When running ChemoMetec's price analysis, check to measure ChemoMetec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec is operating at the current time. Most of ChemoMetec's value examination focuses on studying past and present price action to predict the probability of ChemoMetec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec's price. Additionally, you may evaluate how the addition of ChemoMetec to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |